脱氢吴茱萸碱经免疫-肠道菌群调控增强PEDV疫苗效力
本研究评估天然喹唑啉生物碱脱氢吴茱萸碱(DHED)作为PEDV疫苗佐剂的潜力。体外实验显示6.25 μg/mL DHED可上调RAW264.7巨噬细胞中IL-1β、TNF-α、IL-6和IL-10的mRNA表达。BALB/c小鼠体内实验表明DHED显著提升疫苗诱导的PEDV特异性IgG和肠道SIgA水平、血清IFN-γ和IL-4浓度及CD4+ T细胞活化,并伴随肠道菌群组成改变。
要点
- DHED在体外可上调巨噬细胞IL-1β、TNF-α、IL-6和IL-10的mRNA表达。
- DHED增强PEDV疫苗诱导的体液与细胞免疫应答。
- DHED的免疫增强作用伴随肠道菌群丰富度和多样性增加。
核心结论
- DHED是颇具前景的天然佐剂候选物,可诱导体液和细胞免疫并克服传统佐剂的局限性。
- DHED通过协同调节免疫应答和肠道微生物群落来提升PEDV疫苗效力。
研究设计与样本
- 体外实验:用6.25 μg/mL DHED处理RAW264.7巨噬细胞,RT-qPCR检测细胞因子mRNA表达。
- 体内实验:BALB/c小鼠灌胃给予DHED并配合商业PEDV疫苗免疫。
- 16S rRNA测序分析DHED联合PEDV疫苗对肠道菌群组成的影响。
主要发现
- 6.25 μg/mL DHED显著上调RAW264.7巨噬细胞中IL-1β、TNF-α、IL-6和IL-10的mRNA表达。
- DHED显著提高疫苗诱导的PEDV特异性IgG和肠道SIgA水平。
- DHED上调血清IFN-γ和IL-4浓度,促进外周血和脾脏CD4+ T细胞活化,提高CD3+CD4+/CD3+CD8+比值和脾指数。
- DHED联合PEDV疫苗增加肠道菌群丰富度和多样性,调节有益菌相对丰度,富集免疫相关菌群如Lachnospiraceae、Lachnospiraceae_NK4A136_group、unclassified_f_Lachnospiraceae。
临床怎么用
- DHED可作为PEDV疫苗的天然佐剂候选物,通过免疫-肠道菌群协同调控增强疫苗效力。
- 本研究为DHED在猪群PEDV防控中的临床应用提供了实验证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Porcine Epidemic Diarrhea Virus (PEDV) is a major pathogen of severe enteric disease and mortality in neonatal piglets, and currently available vaccines often provide incomplete and inconsistent protective immunity. The limited immunostimulatory capacity and safety concerns associated with conventional vaccine adjuvants necessitate the development of alternative adjuvants with improved efficacy and biocompatibility. This study evaluated the adjuvant potential of Dehydroevodiamine (DHED), a natural quinazoline alkaloid isolated from Euodiae Fructus, in synergistically enhancing PEDV vaccine-induced humoral and cellular immune responses. In vitro, RT-qPCR results demonstrated that 6.25 μg/mL DHED significantly upregulated the mRNA expression of IL-1β, TNF-α, IL-6, and IL-10 in RAW264.7 macrophages, indicating immunomodulatory potential. In vivo, BALB/c mice were intragastrically administered DHED in conjunction with immunization using a commercial PEDV vaccine. DHED significantly elevated vaccine-induced PEDV-specific IgG and intestinal SIgA levels, upregulated serum IFN-γ and IL-4 concentrations, and promoted CD4+ T-cell activation in peripheral blood and spleen, along with increased CD3+CD4+/CD3+CD8+ ratios and splenic index, thus enhancing the vaccine's immunoefficacy. Furthermore, 16S rRNA sequencing revealed that DHED-mediated immune enhancement was accompanied by significant alterations in intestinal microbiota composition. Co-administration with PEDV vaccine increased gut microbiota richness and diversity, regulated the relative abundance of beneficial bacteria, and enriched immune-related taxa (e.g., Lachnospiraceae, Lachnospiraceae_NK4A136_group, unclassified_f_Lachnospiraceae) to potentiate immune responses. Collectively, DHED emerges as a promising adjuvant candidate, inducing robust cellular and humoral immunity while overcoming the limitations of conventional adjuvants. These findings suggest that DHED represents a promising natural adjuvant candidate for improving PEDV vaccine efficacy through coordinated modulation of immune responses and intestinal microbial communities. Together, our study provides a safe and innovative adjuvant strategy for PEDV control in swine herds, and offer robust experimental evidence supporting the clinical application of DHED.
引用
- Zhang X, Wang H, Li K, et al. Dehydroevodiamine enhances PEDV vaccine efficacy through immune-gut microbiota modulation. Vaccine. 2026. PMID: 41812636. doi:10.1016/j.vaccine.2026.128411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。